
News|Podcasts|March 21, 2024
Phosgene at Valsynthese: An Atom-Economic Reagent That Demonstrates Exceptional Versatility
Author(s)Valsynthese
Dr. Luca Mantilli, R&D chemist at Valsynthese, the fine chemical unit of the Société Suisse des Explosifs Group (SSE), will guide you through the journey that Valsynthese as CDMO has done in phosgenation. The advantages and synthetic possibilities of phosgene, an extremely versatile reagent, will be highlighted with respect to other alternatives, same as the safety measures needed when working with such hazardous building blocks.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
US Government Shutdown: Treating Regulatory Lapses as Predictable Operational Risks
2
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
3
Rare Disease Therapies: From Niche Experiment to Strategic Growth Engine
4
Cellares Secures $257M to Scale Global Cell Therapy Manufacturing
5



